当前位置：首页 > 文献互助 > 互助详情

First-line sacituzumab tirumotecan with tagitanlimab in advanced non-small-cell lung cancer: a phase 2 trial复制

LUCKY 8个月前 245 10 已关闭

DOI: 10.1038/s41591-025-03883-5复制

文献链接:复制

其他信息:

上一篇：Extracting resources from abandoned mines

下一篇：Sacituzumab tirumotecan in advanced non-small-cell lung cancer with or without EGFR mutations: phase 1/2 and phase 2 trials

互助时间线

2025-09-20 21:12:18 [关闭求助]

楼主LUCKY关闭了求助

2025-09-20 19:39:05 [发起求助]

最新发布的求助

Pimavanserin for negative symptoms of schizophrenia: results from the ADVANCE phase 2 randomised, placebo-controlled trial in North America and Europe 11分钟前
Assessment of cartilage regeneration in initial and second-look arthroscopy following low tibial osteotomy for varus osteoarthritis of the ankle 1小时前
Lead Optimization of TgCDPK1 Inhibitors for the Treatment of Toxoplasmosis 1小时前
Linker-Driven Sampling of PROTAC-Induced Ternary Complexes 1小时前
Viscoelastic Supramolecular Hyaluronan-Peptide Cross-Linked Hydrogels 1小时前
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria 2小时前
Difluoroenol phosphinates as difluoroenolate surrogates: synthesis and applications in defluorination and deoxygenative coupling 2小时前
基于全基因组的金针菇光受体基因鉴定及表达分析 3小时前
15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial 3小时前
Nonprecious Core–Shell Catalysts for Durable High-Performance Water Electrolysis 3小时前
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association 3小时前
Pharmacological evaluation of Orai-1 inhibitor in 3-nitropropionic acid-induced Huntington disease 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com